Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide IVIG market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.3% during the forecast period.
This report presents the market size and development trends by detailing the IVIG market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the IVIG market will be shown in this report. In short, this report will comprehensively reveal the characteristics of IVIG industry and will help you to build a panoramic view of the industrial development.
IVIG Market, By Type:
Injection
Lyophilized Powder
IVIG Market, By Application:
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multifocal Motor Neuropathy (MMN)
Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Dermatomyositis
Polymyositis
Some of the leading players are as follows:
BSV
YUAN DA SHUYANG
WIBP
Tiantan Bio
Weiguang Bio
Hualan Bio
RAAS
Weilun Bio
RUIDE Bio
BOYA Bio
SIBP
Xinxing Medicine
BOYA Bio
Kangbao Bio
TONROL
YUAN DA SHUYANG
Taibang Bio
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 IVIG Market: Technology Type Analysis
-
4.1 IVIG Technology Type Market Share Analysis, 2018 & 2026
-
4.2 IVIG Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Injection
4.3.2 Lyophilized Powder
5 IVIG Market: Product Analysis
-
5.1 IVIG Product Market Share Analysis, 2018 & 2026
-
5.2 IVIG Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 IVIG Market: Application Analysis
-
6.1 IVIG Application Market Share Analysis, 2018 & 2026
-
6.2 IVIG Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Multiple Sclerosis (MS)
6.3.2 Myasthenia Gravis (MG)
6.3.3 Multifocal Motor Neuropathy (MMN)
6.3.4 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
6.3.5 Dermatomyositis
6.3.6 Polymyositis
7 IVIG Market: Regional Analysis
-
7.1 IVIG Regional Market Share Analysis, 2018 & 2026
-
7.2 IVIG Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 BSV
9.1.1 BSV Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 YUAN DA SHUYANG
9.2.1 YUAN DA SHUYANG Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 WIBP
9.3.1 WIBP Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Tiantan Bio
9.4.1 Tiantan Bio Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Weiguang Bio
9.5.1 Weiguang Bio Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Hualan Bio
9.6.1 Hualan Bio Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 RAAS
9.7.1 RAAS Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Weilun Bio
9.8.1 Weilun Bio Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 RUIDE Bio
9.9.1 RUIDE Bio Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 BOYA Bio
9.10.1 BOYA Bio Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 SIBP
9.11.1 SIBP Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Xinxing Medicine
9.12.1 Xinxing Medicine Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 BOYA Bio
9.13.1 BOYA Bio Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Kangbao Bio
9.14.1 Kangbao Bio Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 TONROL
9.15.1 TONROL Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 YUAN DA SHUYANG
9.16.1 YUAN DA SHUYANG Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Taibang Bio
9.17.1 Taibang Bio Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
The List of Tables and Figures (Totals 89 Figures and 127 Tables)
Figure Injection IVIG market, 2015 - 2026 (USD Million)
Figure Lyophilized Powder IVIG market, 2015 - 2026 (USD Million)
Figure Multiple Sclerosis (MS) market, 2015 - 2026 (USD Million)
Figure Myasthenia Gravis (MG) market, 2015 - 2026 (USD Million)
Figure Multifocal Motor Neuropathy (MMN) market, 2015 - 2026 (USD Million)
Figure Multifocal Acquired Sensory and Motor Neuropathy (MADSAM) market, 2015 - 2026 (USD Million)
Figure Dermatomyositis market, 2015 - 2026 (USD Million)
Figure Polymyositis market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America IVIG market, by country, 2015 - 2026 (USD Million)
-
Table North America IVIG market, by type, 2015 - 2026 (USD Million)
-
Table North America IVIG market, by product, 2015 - 2026 (USD Million)
-
Table North America IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. IVIG market, by type, 2015 - 2026 (USD Million)
-
Table U.S. IVIG market, by product, 2015 - 2026 (USD Million)
-
Table U.S. IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Canada IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Canada IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Europe IVIG market, by country, 2015 - 2026 (USD Million)
-
Table Europe IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Europe IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Europe IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. IVIG market, by type, 2015 - 2026 (USD Million)
-
Table U.K. IVIG market, by product, 2015 - 2026 (USD Million)
-
Table U.K. IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Germany IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Germany IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France IVIG market, by type, 2015 - 2026 (USD Million)
-
Table France IVIG market, by product, 2015 - 2026 (USD Million)
-
Table France IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Italy IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Italy IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Spain IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Spain IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific IVIG market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China IVIG market, by type, 2015 - 2026 (USD Million)
-
Table China IVIG market, by product, 2015 - 2026 (USD Million)
-
Table China IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Japan IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Japan IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India IVIG market, by type, 2015 - 2026 (USD Million)
-
Table India IVIG market, by product, 2015 - 2026 (USD Million)
-
Table India IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Latin America IVIG market, by country, 2015 - 2026 (USD Million)
-
Table Latin America IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Latin America IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Latin America IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Brazil IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Brazil IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Mexico IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Mexico IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Argentina IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Argentina IVIG market, by application, 2015 - 2026 (USD Million)
-
Table MEA IVIG market, by country, 2015 - 2026 (USD Million)
-
Table MEA IVIG market, by type, 2015 - 2026 (USD Million)
-
Table MEA IVIG market, by product, 2015 - 2026 (USD Million)
-
Table MEA IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa IVIG market, by type, 2015 - 2026 (USD Million)
-
Table South Africa IVIG market, by product, 2015 - 2026 (USD Million)
-
Table South Africa IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria IVIG market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria IVIG market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria IVIG market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table BSV Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table YUAN DA SHUYANG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table WIBP Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tiantan Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Weiguang Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hualan Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table RAAS Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Weilun Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table RUIDE Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BOYA Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SIBP Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Xinxing Medicine Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BOYA Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Kangbao Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table TONROL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table YUAN DA SHUYANG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Taibang Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
